October 22, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: | Suzanne Hayes Ibolya Ignat Lisa Vanjoske Ada Sarmento |
Re: | Phathom Pharmaceuticals, Inc. |
Registration Statement on Form S-1 (File No. 333-234020)
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between October 15, 2019 and the date hereof, approximately 3,523 copies of the Preliminary Prospectus dated October 15, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Washington, D.C. time, on Thursday, October 24, 2019 or as soon thereafter as practicable, or at such other time thereafter as the Company or its counsel, Latham & Watkins LLP, request by telephone that such Registration Statement be declared effective.
[Signature page follows]
Very truly yours,
GOLDMAN SACHS & CO. LLC
JEFFERIES LLC
EVERCORE GROUP L.L.C.
As representatives of the Underwriters
By: | Goldman Sachs & Co. LLC | |
By: | /s/ Kristen Grippi | |
Name: Kristen Grippi | ||
Title: Managing Director | ||
By: | Jefferies LLC | |
By: | /s/ Charles L Glazer | |
Name: Charles L Glazer | ||
Title: Managing Director | ||
By: | Evercore Group L.L.C. | |
By: | /s/ Gloria Tang | |
Name: Gloria Tang | ||
Title: Vice President |
[Signature page to Acceleration Request]